Schizophrenia News and Research

Latest Schizophrenia News and Research

Oxytocin helps humans accept others, study finds

Oxytocin - often referred to as the 'love hormone' because of its ability to promote mother-infant attachment and romantic bonding in adults - could also make us more accepting of other people, as found in new research, "Oxytocin Sharpens Self-other Perceptual Boundary," by Neuropsychoanalysis Foundation research grantee Valentina Colonnello Ph.D. published online today in Psychoneuroendocrinology.

30 Sep 2013

Short insight scale validated for schizophrenia in clinical practice

Researchers have validated a short version of the Scale to Assess Unawareness in Mental Disorder, with the aim of encouraging assessment of insight in patients with schizophrenia in clinical practice.

27 Sep 2013

Cogstate test shows effective treatment option for schizophrenia

Medical technology company Cogstate continues to strengthen its position as an essential partner for measuring cognition in important studies around the world, with results from a schizophrenia study using Cogstate's test published in a major scientific journal.

27 Sep 2013

Researchers confirms strong link between preterm birth and risk of infant death, autism and ADHD

An unprecedented study of preterm birth suggests that only some of the problems previously associated with preterm birth are actually caused by preterm birth itself.

27 Sep 2013

Study shows how maternal viral infection may increase risk of having child with autism

Activating a mother's immune system during her pregnancy disrupts the development of neural cells in the brain of her offspring and damages the cells' ability to transmit signals and communicate with one another, researchers with the UC Davis Center for Neuroscience and Department of Neurology have found.

27 Sep 2013

Drug misuse predicts protracted hospital stay for schizophrenia patients

Patients hospitalized with schizophrenia have more severe symptoms and spend longer in hospital if they have a concurrent substance use disorder, report researchers.

26 Sep 2013

Early intermodality dysfunction predicts schizophrenia risk

Researchers have found abnormalities in the way infants of parents with schizophrenia perceive the way they move and how this relates to vision, touch, hearing, and orientation.

25 Sep 2013

Exposure to cocaine during in utero development causes disruptions in normal brain development

Prenatal cocaine exposure affects both behavior and brain. Animal studies have shown that exposure to cocaine during in utero development causes numerous disruptions in normal brain development and negatively affects behavior from birth and into adulthood.

25 Sep 2013

Prefrontal glutamate abnormalities confined to established psychosis

Abnormalities in glutamate and glutamine levels in the prefrontal cortex are only present in patients with chronic schizophrenia, say researchers.

24 Sep 2013

Inflammation tracks mania course

Markers of inflammation are elevated in patients who are hospitalized for acute mania, a study shows.

24 Sep 2013

Study: Messages coming from muscle receptors are enough to change the internal body representation

People can be easily tricked into believing an artificial finger is their own, shows a study published today [23 September] in The Journal of Physiology.

23 Sep 2013

Research on synapse stabilization aids understanding of autism, schizophrenia, intellectual disability

When we're born, our brains aren't very organized. Every brain cell talks to lots of other nearby cells, sending and receiving signals across connections called synapses.

21 Sep 2013

Adolescents with psychosis face long treatment delays

Adolescents have a duration of untreated psychosis that is approximately twice that seen in adults, UK study findings show.

20 Sep 2013

Visual clue to schizophrenia pathology

Researchers say that retinal imaging could be a useful tool for studying some of the pathologic processes associated with schizophrenia.

19 Sep 2013

Omeros announces initiation of enrollment in OMS824 Phase 2 trial for schizophrenia

Omeros Corporation today announced initiation of enrollment in a Phase 2 clinical trial of OMS824, the company's phosphodiesterase 10 inhibitor. The trial will evaluate the compound's tolerability, safety, pharmacokinetics, potential interactions with concomitant antipsychotic medications, and a battery of cognitive tests in patients with stable schizophrenia.

19 Sep 2013

Scientist develop novel system to monitor behavior of patients suffering from schizophrenia

Schizophrenia is a potentially debilitating mental illness affecting a person's thought processes, perception, language and sense of oneself.

19 Sep 2013

Toxoplasma infection makes mice fearless

The Toxoplasma parasite can be deadly, causing spontaneous abortion in pregnant women or killing immune-compromised patients, but it has even stranger effects in mice.

19 Sep 2013

Neuropsychologic decline precedes schizophrenia onset

Researchers have confirmed that neuropsychologic functioning declines in individuals with schizophrenia from before to after illness onset.

18 Sep 2013

Children with 22q11.2 deletion syndrome may often be misdiagnosed to have autism

Children with a genetic disorder called 22q11.2 deletion syndrome, who frequently are believed to also have autism, often may be misidentified because the social impairments associated with their developmental delay may mimic the features of autism, a study by researchers with the UC Davis MIND Institute suggests.

18 Sep 2013

Cardiovascular mortality in schizophrenia may be underestimated

Cardiovascular causes account for about a quarter of deaths of patients with schizophrenia and may also contribute to the high rate of unexplained deaths, say researchers.

17 Sep 2013

Schizophrenia News and Research

Latest Schizophrenia News and Research

Oxytocin helps humans accept others, study finds

Short insight scale validated for schizophrenia in clinical practice

Cogstate test shows effective treatment option for schizophrenia

Researchers confirms strong link between preterm birth and risk of infant death, autism and ADHD

Study shows how maternal viral infection may increase risk of having child with autism

Drug misuse predicts protracted hospital stay for schizophrenia patients

Early intermodality dysfunction predicts schizophrenia risk

Exposure to cocaine during in utero development causes disruptions in normal brain development

Prefrontal glutamate abnormalities confined to established psychosis

Inflammation tracks mania course

Study: Messages coming from muscle receptors are enough to change the internal body representation

Research on synapse stabilization aids understanding of autism, schizophrenia, intellectual disability

Adolescents with psychosis face long treatment delays

Visual clue to schizophrenia pathology

Omeros announces initiation of enrollment in OMS824 Phase 2 trial for schizophrenia

Scientist develop novel system to monitor behavior of patients suffering from schizophrenia

Toxoplasma infection makes mice fearless

Neuropsychologic decline precedes schizophrenia onset

Children with 22q11.2 deletion syndrome may often be misdiagnosed to have autism

Cardiovascular mortality in schizophrenia may be underestimated

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Schizophrenia News and Research

Latest Schizophrenia News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in